DL-AP3

CAS No. 20263-06-3

DL-AP3( —— )

Catalog No. M23907 CAS No. 20263-06-3

DL-AP3 is a competitive group I metabotropic glutamate receptor antagonist and inhibitor of phosphoserine phosphatase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 26 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DL-AP3
  • Note
    Research use only, not for human use.
  • Brief Description
    DL-AP3 is a competitive group I metabotropic glutamate receptor antagonist and inhibitor of phosphoserine phosphatase.
  • Description
    DL-AP3 is a competitive group I metabotropic glutamate receptor antagonist and inhibitor of phosphoserine phosphatase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Neuroscience
  • Target
    GluR
  • Recptor
    Glutamate receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    20263-06-3
  • Formula Weight
    169.07
  • Molecular Formula
    C3H8NO5P
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:<1 mg/mL;Ethanol:<1 mg/mL;H2O:12.05 mg/mL
  • SMILES
    C(C(C(=O)O)N)P(=O)(O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Di C , Xu J , Xu Q , et al. DL-2-amino-3-phosphonopropionic acid protects primary neurons from oxygen-glucose deprivation induced injury[J]. Bosn J Basic Med, 2017, 17(1).
molnova catalog
related products
  • Caroverine HCL

    Caroverine HCL is a potent, competitive and reversible antagonist of NMDA and AMPA glutamate receptor. It?is also an antioxidant and calcium-blocking agent that exhibits vasorelaxant action, and?can be used for the research of inner ear tinnitus.

  • LY382884

    LY382884 is a selective and potent GluR5 kainate receptor antagonist with anxiolytic activity.LY382884 blocks blockade of mossy fibre LTP induction.

  • DMeOB

    DMeOB (3,3'-Dimethoxybenzaldazine) is a negative regulator with mGluR5 agonist activity and can be used to study neurological diseases.